Enrollment is under way for a national randomized study to assess the efficacy of a new fertility drug that would require one weekly injection rather than daily injections to stimulate the ovaries.
Enrollment is under way for a national randomized study to assess the efficacy of a new fertility drug that would require one weekly injection rather than daily injections to stimulate the ovaries.
Women between 35 and 42 years of age may qualify for a cycle of in vitro fertilization at no cost, according to an announcement from the Women’s and Infant’s Hospital of Rhode Island in Providence, which is one of the centers participating in the trial. The hospital’s Center for Reproduction and Infertility is enrolling patients for the study in Providence, Boston, and 9 other locations.
“This new drug would require a single injection that lasts 7 days” to stimulate the ovaries to produce eggs instead of the daily injections required by traditional infertility treatment, explains lead investigator Bala Bhagavath, MD.
“This is obviously much easier for the patient, and we’re hoping it will be equally, if not more, effective than the current drugs available,” Bhagavath says.
More information about the study is available from Patty Pursue at the Center for Reproduction and Infertility, (401) 453-7500, extension 8404.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More